Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study

Andrejs Ērglis; Sujith Seneviratne; Darren Walters; Robert Whitbourn; Jamie Layland; Jim Stewart; Seif El-Jack; Thomas Christen; Dominic Allocco; Ian Meredith

doi:10.1016/j.jacc.2017.09.1054

Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study

Andrejs Ērglis
, Sujith Seneviratne
, Darren Walters
, Robert Whitbourn
, Jamie Layland
, Jim Stewart
, Seif El-Jack
, Thomas Christen
, Dominic Allocco
, Ian Meredith

Institute of Cardiology and Regenerative Medicine

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Journal	Journal of the American College of Cardiology
Volume	70
Issue number	18
DOIs	https://doi.org/10.1016/j.jacc.2017.09.1054
Publication status	Published - 2017
Event	29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT) - Denver, CO, United States Duration: 29 Oct 2017 → 2 Nov 2017 Conference number: 29

OECD Field of Science

3. Medical and Health Sciences

Access to Document

10.1016/j.jacc.2017.09.1054

Cite this

Ērglis, A., Seneviratne, S., Walters, D., Whitbourn, R., Layland, J., Stewart, J., El-Jack, S., Christen, T., Allocco, D., & Meredith, I. (2017). Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study. Journal of the American College of Cardiology, 70(18). https://doi.org/10.1016/j.jacc.2017.09.1054

@article{2afc7d0042e84a028496565bb3ca0836,

title = "Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study",

author = "Andrejs Ērglis and Sujith Seneviratne and Darren Walters and Robert Whitbourn and Jamie Layland and Jim Stewart and Seif El-Jack and Thomas Christen and Dominic Allocco and Ian Meredith",

year = "2017",

doi = "10.1016/j.jacc.2017.09.1054",

language = "English",

volume = "70",

journal = "Journal of the American College of Cardiology",

issn = "0735-1097",

publisher = "Elsevier Inc.",

number = "18",

note = "29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT) ; Conference date: 29-10-2017 Through 02-11-2017",

}

Ērglis, A, Seneviratne, S, Walters, D, Whitbourn, R, Layland, J, Stewart, J, El-Jack, S, Christen, T, Allocco, D & Meredith, I 2017, 'Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study', Journal of the American College of Cardiology, vol. 70, no. 18. https://doi.org/10.1016/j.jacc.2017.09.1054

Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study. / Ērglis, Andrejs; Seneviratne, Sujith; Walters, Darren et al.
In: Journal of the American College of Cardiology, Vol. 70, No. 18, 2017.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study

AU - Ērglis, Andrejs

AU - Seneviratne, Sujith

AU - Walters, Darren

AU - Whitbourn, Robert

AU - Layland, Jamie

AU - Stewart, Jim

AU - El-Jack, Seif

AU - Christen, Thomas

AU - Allocco, Dominic

AU - Meredith, Ian

N1 - Conference code: 29

PY - 2017

Y1 - 2017

UR - https://www.sciencedirect.com/science/article/pii/S0735109717408825

U2 - 10.1016/j.jacc.2017.09.1054

DO - 10.1016/j.jacc.2017.09.1054

M3 - Meeting abstract

SN - 0735-1097

VL - 70

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

IS - 18

T2 - 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT)

Y2 - 29 October 2017 through 2 November 2017

ER -

Clinical Outcomes in Patients Treated With the Fully Absorbable, Everolimus-Eluting RENUVIATM Scaffold: Primary Endpoint Results from the FAST First Human Use Study

OECD Field of Science

Access to Document

Other files and links

Cite this